All posts

The IPO Window Is Open—But Liquidity Is the Real Test

Strong issuance is only the first step; durable aftermarket liquidity is the harder measure of a healthy capital-markets window.

A market participant reviews stock-market data on a tablet.
Photo by Jakub Zerdzicki on PexelsPhoto by Mufid Majnun on Pexels

A market participant reviews stock-market data on a tablet.

The U.S. equity-issuance window is open—but the more important question for investors and issuers is whether public-market liquidity can absorb new supply without making price discovery unusually fragile.

The headline is strong; the distribution is narrower

U.S.-focused equity-capital-markets activity produced $297.1 billion of proceeds in the first half of 2026, according to Houlihan Lokey’s Q2 update, while IPO deal count nearly doubled year over year.[1] That is a meaningful improvement from the thin issuance environment of recent years, but headline proceeds can be dominated by very large transactions. FTI Consulting described Q2 as a quarter defined by a mega-IPO and a broader recovery in global IPO markets.[2]

The practical implication is that “the IPO market is back” is too broad a conclusion. A healthier test is whether activity is spreading across deal sizes and sectors, whether follow-on sellers can access the market, and whether newly listed stocks develop durable two-sided trading after the first week.

August is offering a more selective signal

Recent calendar coverage shows a mixed but constructive pattern. Three companies priced offerings and one SPAC in the week through August 14, even as the month was described as an August lull.[3] Biotech has been the clearest pocket of momentum: IPOScoop reported five biotech IPOs targeting a combined $972 million early in August, while four deals covered in a later weekly recap raised $1.17 billion after increasing deal sizes at pricing.[3]

A controlled biotechnology laboratory setting reflects the sector concentration in recent IPO activity.

That does not establish a universal risk appetite. It does show that investors are willing to fund specific narratives when the syndicate, disclosure package, and perceived pipeline are persuasive. Biotech also makes the aftermarket test especially important: clinical milestones can create sharp gaps, and a successful offering does not guarantee continuous liquidity.

Issuance is only half of the supply equation

New IPO shares and secondary offerings add tradable supply, but buybacks can offset some of that pressure. A current TTM ranking updated August 3 places Apple’s reported buyback spend at $82.23 billion through the fiscal period ended June 27, 2026.[4] Buyback authorizations, however, are not the same as shares retired; the relevant market-structure question is the net change in shares outstanding after employee compensation, conversions, follow-ons, and repurchases.

This matters because gross issuance can overstate dilution when repurchases are active, while gross buyback headlines can understate supply when equity compensation is substantial. The clean comparison is not “IPO dollars versus buyback dollars” in isolation, but the interaction of:

Supply or demand channel What it changes Evidence to check
IPO Creates a new public float and tests primary demand Offer size, allocation, first-week turnover, price stability
Follow-on or secondary Adds shares or permits existing holders to sell Selling shareholders, primary/secondary mix, lockup terms
Lockup expiration Can increase potential float after the restricted period Actual selling, borrow conditions, turnover—not just the calendar date
Buyback Can reduce shares outstanding and provide demand Cash spent, shares retired, dilution from compensation
Market-making capacity Shapes execution and price discovery Spreads, depth, volatility, halts, and off-exchange activity

Market plumbing is moving into the foreground

On June 11, the SEC proposed rescinding Regulation NMS Rule 611’s trade-through prohibition and Rule 610(e)’s restrictions on locked and crossed quotations.[5] The proposal is not a final rule, and its effects cannot be treated as settled. But it puts a structural question directly on the agenda: how much protection should the national market system impose on displayed quotes, and how much flexibility should venues and market participants have to compete on routing, pricing, and execution?

For IPOs and secondary offerings, that debate is not abstract. Newly listed shares often have uneven depth, fast-moving quotes, and a high dependence on market makers to turn fragmented interest into orderly trading. Any change in the rules governing quote interaction could alter the balance among displayed liquidity, execution speed, venue competition, and the cost of trading. The direction of the effect is not predetermined; it will depend on the final rule, implementation, and how participants adapt.

What the August tape is saying

The August 18 session supplied a reminder that liquidity and volatility can diverge from issuance optimism. QQQ fell 1.69%, while high-dollar-volume semiconductor names including MU, SNDK, NVDA, AMD, and SMH also declined; the session’s volume-leader data showed MU down 7.02% and SNDK down 9.01%.[6] This is not evidence that IPO demand has failed, nor does it identify a single cause for the moves. It does show that a market capable of absorbing large issuance can still reprice crowded or highly sensitive exposures quickly.

A balanced interpretation is therefore warranted. The base case is a functioning issuance window with episodic openings rather than a frictionless boom. The more optimistic case requires breadth, stable aftermarkets, and continued balance between gross issuance and net share-count change. The more cautious case would show up as deals pricing only in narrow hot spots, weak post-listing depth, frequent volatility interruptions, or secondary supply arriving faster than natural demand.

Checklist for reading a new deal

  • Primary versus secondary: Is the company raising capital, existing holders selling, or both?
  • Float and concentration: How much stock is actually available to trade, and how concentrated are allocations?
  • Lockup mechanics: What restrictions apply, and what happens when they expire?
  • Aftermarket quality: Are spreads, turnover, and depth improving after the opening sessions?
  • Sector breadth: Is issuance expanding beyond the strongest current narrative?
  • Net supply: Are buybacks and employee-related issuance changing the share-count picture?
  • Rule risk: Could pending exchange or SEC changes alter routing, quote interaction, or displayed liquidity?

What to watch next

  1. Breadth of the calendar. Track whether late-summer and early-fall deals broaden beyond biotech and other high-momentum pockets.
  2. Pricing quality. Compare proposed ranges with final pricing and then follow first-week turnover and price discovery; a deal priced successfully is not necessarily a liquid market.
  3. Secondary supply. Watch registered follow-ons, insider and sponsor sell-downs, and lockup-related filings for actual float expansion.
  4. Net share counts. Read quarterly filings for shares retired through buybacks alongside stock-based compensation and conversion effects.
  5. Regulation NMS comments and implementation. The SEC’s proposal has a 60-day comment period after Federal Register publication.[5] The final language and transition timetable matter more than the existence of the proposal alone.
  6. Volatility under stress. Use broad-market and sector volume, spreads, depth, and trading interruptions to distinguish healthy price discovery from liquidity that disappears when demand becomes one-sided.

The IPO window is open, but its durability will be measured in the aftermarket. Capital formation is improving; market structure will determine how much of that improvement becomes repeatable access rather than a sequence of isolated bursts.

Sources

  1. Equity Capital Markets Update Q2 2026cdn.hl.com
  2. IPO & SPAC Market Update: Q2 2026 | FTIfticonsulting.com
  3. US IPO Weekly Recap: Copper foils producer and metabolic disorders biotech list amid Augu…longbridge.com
  4. Largest Companies by Buyback Spend — TTM Buyback Rankingstickerleague.com
  5. SEC.gov | SEC Proposes Rescission of Regulation NMS Rules 611 and 610(e)sec.gov
  6. Stock SQL: volume_leadersFN2 market data